This notion, together with previous evidence showing that gut epithelial cells express IL-21R and respond to IL-21 [33], prompted us to investigate whether IL-21 can activate STAT3 and NF-kB in human CRC cells. The gene discussed is NFKB1; the disease is colorectal carcinoma.